Shukra Pharmaceuticals Ltd.
Snapshot View

View in App

Prices View details >>

52.25 +2.48 ▲5.0%

22 March 2023, 03:22:00 PM
Volume: 3,888

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.shukrapharmaceuticals.com
Market Cap 57.26 Cr.
Enterprise Value(EV) 56.28 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.98 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 53.32 Trailing Twelve Months Ending 2022-12
Industry PE 31.70 Trailing Twelve Months Ending 2022-12
Book Value / Share 23.88 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.19 Calculated using Price: 52.25
Dividend Yield 0.20 Period Ending 2022-03
No. of Shares Subscribed 1.10 Cr. 10,959,725 Shares
FaceValue 10
Company Profile
The company is engaged in the business of manufacturing and trading of pharmaceuticals Products, laboratory testing.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+4.98%
1 Week
+19.24%
1 Month
-16.06%
3 Month
+85.88%
6 Month
+24.23%
1 Year
+279.17%
2 Year
+482.50%
5 Year
+311.42%
10 Year
+18560.71%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -11.39 0.94 0.85 3.51 3.55 3.04 0.23 1.21 4.70
Return on Capital Employed (%) -5.78 1.83 2.40 7.41 5.94 3.62 0.77 0.54 5.79
Return on Assets (%) -4.80 0.72 0.67 2.78 2.44 1.76 0.11 0.54 2.12

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 14 14 14 15 15 15 15 16 16 17
Non Curr. Liab. 2 3 2 3 6 9 11 13 6 5
Curr. Liab. 2 1 1 2 3 4 7 7 12 10
Minority Int.
Equity & Liab. 18 18 17 19 24 28 34 36 35 31
Non Curr. Assets 11 11 11 12 16 17 19 20 19 20
Curr. Assets 7 7 6 7 8 11 14 16 16 11
Misc. Exp. not W/O
Total Assets 18 18 17 19 24 28 34 36 35 31

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 4 3 5 5 5 6 12 11 20 22
Other Income 0 1 0 0 0 0 0 0 0 0
Total Income 5 4 5 5 5 6 12 12 21 22
Total Expenditure -5 -3 -4 -4 -4 -4 -10 -10 -18 -18
PBIDT 0 1 1 2 2 2 2 2 3 4
Interest 0 0 0 0 0 0
Depreciation -1 -1 0 0 -1 -1 -1 -1 -2 -2
Taxation 0 0 0 -1 0 0 0 0 0 0
Exceptional Items 0 -1 0 0
PAT -1 0 0 1 1 0 0 0 1 1
Adjusted EPS -1 0 0 1 1 1 0 0 1 1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 10 -3 -2 3 0 1 0 1 1 8
Cash Fr. Inv. -11 2 1 0 -1 -5 -2 -3 -2 -2
Cash Fr. Finan. 1 2 1 -1 3 2 2 2 -7
Net Change 0 0 0 1 -1 0 0 0 0 0
Cash & Cash Eqvt 0 1 1 2 1 0 0 0 1 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 49.17 49.17 49.17 49.17 49.17 49.17 49.17 49.17 49.17
Public 50.83 50.83 50.83 50.83 50.83 50.83 50.83 50.83 50.83
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 17 Mar 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
This is to inform you that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 the Newspaper publication regarding Basis of Allotment in Rights Issue have been published in the in English Hindi and Gujarati (Regional Language) newspapers on 14th March 2023
Mon, 13 Mar 2023
Intimation Of Independent Directors Meeting To Be Held On 24Th March 2023
i. Review the performance of Non-Independent Directors and the Board as whole.ii. Review performance of the Chairperson of the Company.iii. Access the Quantity Quality and timeliness of flow of information.iv. Any other business with the permission of Chair.
Sat, 11 Mar 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Yogesh Biharilal Parikh

Technical Scans View Details >>

Tue, 21 Mar 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at High Opening at High
Closing Above Previous High Closing Above Previous High

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,474.95 +1.3%
Divi's Laboratories Ltd. 73,553.38 2,790.65 +0.8%
Cipla Ltd. 69,632.88 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. 51,277.87 1,518.60 +0.2%
Zydus Lifesciences Ltd. 48,378.30 478.65 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-12 26.39 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 478.65 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-12 3.07 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 478.65 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 0.04 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 478.65 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 478.65 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 478.65 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 478.65 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 478.65 +0.1%

FAQ's On Shukra Pharmaceuticals Ltd.

What is Shukra Pharma share price?
Can I buy Shukra Pharma shares now?
What is the Dividend Yield of Shukra Pharma?
What is the Market Cap of Shukra Pharma?
What are the key metrics to analyse Shukra Pharma?
What is the 52 Week High and Low of Shukra Pharma?
What is the trend of Shukra Pharma share price?